Molecular mechanisms of sorafenib action in liver cancer cells
Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of
advanced hepatocellular carcinoma (HCC). However, as the clinical application of sorafenib …
advanced hepatocellular carcinoma (HCC). However, as the clinical application of sorafenib …
[引用][C] Molecular mechanisms of sorafenib action in liver cancer cells
M Cervello, D Bachvarov, N Lampiasi, A Cusimano… - Cell Cycle, 2012 - cir.nii.ac.jp
Molecular mechanisms of sorafenib action in liver cancer cells
M Cervello, D Bachvarov… - Cell cycle …, 2012 - pubmed.ncbi.nlm.nih.gov
Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of
advanced hepatocellular carcinoma (HCC). However, as the clinical application of sorafenib …
advanced hepatocellular carcinoma (HCC). However, as the clinical application of sorafenib …
[PDF][PDF] Molecular mechanisms of sorafenib action in liver cancer cells
M Cervello, D Bachvarov, N Lampiasi, A Cusimano… - Cell Cycle, 2012 - academia.edu
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer and is currently the third
major cause of cancer-related deaths. 1, 2 Although recent progress in diagnostic and …
major cause of cancer-related deaths. 1, 2 Although recent progress in diagnostic and …
[引用][C] Molecular mechanisms of sorafenib action in liver cancer cells.
M Cervello, D Bachvarov, N Lampiasi, A Cusimano… - CELL CYCLE, 2012 - iris.unipa.it
Molecular mechanisms of sorafenib action in liver cancer cells. IRIS IRIS Home Sfoglia
Macrotipologie & tipologie Autore Titolo Data di pubblicazione Riviste Serie Tipologia IT Italiano …
Macrotipologie & tipologie Autore Titolo Data di pubblicazione Riviste Serie Tipologia IT Italiano …
[PDF][PDF] Molecular mechanisms of sorafenib action in liver cancer cells
M Cervello, D Bachvarov, N Lampiasi, A Cusimano… - Cell …, 2012 - researchgate.net
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer and is currently the third
major cause of cancer-related deaths. 1, 2 Although recent progress in diagnostic and …
major cause of cancer-related deaths. 1, 2 Although recent progress in diagnostic and …
Molecular mechanisms of sorafenib action in liver cancer cells.
M Cervello, D Bachvarov, N Lampiasi… - Cell Cycle …, 2012 - europepmc.org
Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of
advanced hepatocellular carcinoma (HCC). However, as the clinical application of sorafenib …
advanced hepatocellular carcinoma (HCC). However, as the clinical application of sorafenib …
[PDF][PDF] Molecular mechanisms of sorafenib action in liver cancer cells
M Cervello, D Bachvarov, N Lampiasi, A Cusimano… - Cell Cycle, 2012 - academia.edu
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer and is currently the third
major cause of cancer-related deaths. 1, 2 Although recent progress in diagnostic and …
major cause of cancer-related deaths. 1, 2 Although recent progress in diagnostic and …